The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
 
Rachel N. Grisham
Consulting or Advisory Role - Amgen
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Medivation
 
Michael S. Gordon
Research Funding - Array BioPharma
 
Wael A. Harb
Consulting or Advisory Role - Onyx
Research Funding - Horizon Oncology Research
 
Carol Aghajanian
No Relationships to Disclose
 
D. Scott McMeekin
No Relationships to Disclose
 
Kristin McKinley
No Relationships to Disclose
 
Lisa Renee Anderson
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Renae Chavira
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Janna Christy-Bittel
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Emma Barrett
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca; Genentech/Roche; Immunogen
Travel, Accommodations, Expenses - AstraZeneca